Boosting Demand Of Next Generation Sequencing Market Due To Development Of Companion Diagnostics & Personalized Medicine Till 2025
The
global next generation sequencing market is anticipated
to reach USD 21.4 billion by 2025, according to a new report by Grand View
Research, Inc. Increasing coverage of NGS is expected to drive use of precision
medicine in oncology from research based setting to clinical cancer setting.
Commercial payers are also engaged in reviewing the existing and novel tests in
order to establish appropriate medical necessity criteria for their clinical
and medical policies.
UK NGS market revenue, by technology, 2013 - 2024 (USD Million) |
Moreover,
improved understanding of the genetic markers of virulence and resistance
provided by next generation sequencing is expected to drive demand of the
technology in infectious disease diagnosis.
Browse full
research report on Next Generation Sequencing Market:
www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market
Further key
findings from the study suggest:
- Oncology accounted for the dominant share owing
to phase-resolved and unambiguous results obtained by using single assay systems,
and analysis program.
- Targeted resequencing dominated the market
owing to its associated benefits such as implementation of the technique
such as lower turnaround time and more manageable data sets.
- Academic usage of NGS accounted for the largest
share with respect to market revenue by end uses and is anticipated to
maintain its dominance.
- Higher adoption of this technology and
platforms in university projects is expected to support the estimated
share.
- Asia Pacific is estimated to witness the fastest
growth over the forecast period owing to expected routing of a
considerable portion of whole genome sequencing requirements herein.
- Key players operating in the NGS market include
Illumina Inc., Agilent Technologies, BGI, Pacific Biosciences, Qiagen, Roche,
Thermo Fischer Scientific, and Oxford Nanopore Technologies Ltd.
- Endeavors adopted by participants are such as
acquisition of Enzymatics by Qiagen acquired solutions in order to enhance
the product portfolio with respect to reagents needed in preparatory
steps.
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the NGS market on the basis of
application, technology, workflow, and end use:
NGS
Outlook, by Application (Revenue, USD Million; 2014 - 2025)
- Reproductive
Health
- NIPT
- PGT
- Newborn/Genetic
Screening
- Oncology
- HLA
Typing/Immune System Monitoring
- Metagenomics,
Epidemiology & Drug Development
- Agrigenomics
& Forensics
- Consumer
Genomics
- Clinical
Investigation
- Idiopathic
Diseases
- Inherited
Diseases
- Infectious
Diseases
- Non-Communicable
/ Other Diseases
NGS
Outlook, by Technology (Revenue, USD Million; 2014 - 2025)
- Targeted
Sequencing Analysis
- DNA
Based Targeted Sequencing Analysis
- RNA
Based Targeted Sequencing Analysis
- Whole
Genome Sequencing
- Whole
Exome Sequencing
NGS
Outlook, by Workflow (Revenue, USD Million; 2014 - 2025)
- Pre-sequencing
- NGS
Library Preparation Kits
- NGS
Semi-automated Library Preparation
- NGS
Automated Library Preparation
- Clonal
Amplification
- Sequencing
- Data
Analysis
- Primary
Data Analysis
- Secondary
Data Analysis
- Tertiary
Data Analysis
NGS
Outlook, by End-use (Revenue, USD Million; 2014 - 2025)
- Academic
Research
- Clinical
Research
- Hospitals
& Clinics
- Pharma
& Biotech Entities
- Other
Users
NGS
Outlook, by Region (Revenue, USD Million; 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- China
- Japan
- Latin
America
- Brazil
- Middle
East & Africa
- South
Africa
Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-next-generation-sequencing-market
About Grand View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment